Abzena
PolyTherics specializes in proprietary site-specific conjugation technologies for antibody drug conjugate development and solutions for optimisation of the therapeutic properties of biopharmaceuticals.
Antitope is an industry leader in immunogenicity assessment, protein engineering to create humanized antibodies and deimmunised therapeutic proteins and cell line development for manufacture.
The group has built a global customer base over the past decade, including the top 10 pharma, large and small biotech, and academic groups.